Endoscopic Devices - Greece

  • Greece
  • In Greece, revenue in the Endoscopic Devices market market is projected to reach US$107.00m in 2024.
  • This revenue is anticipated to display an annual growth rate (CAGR 2024-2029) of 5.97%, leading to a market volume of US$143.00m by 2029.
  • In a global context, the highest revenue will be generated the United States, with a figure of US$10,390.00m in 2024.
  • In Greece, the increasing prevalence of gastrointestinal disorders is driving demand for advanced endoscopic devices within the medical technology sector.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Greece is witnessing moderate growth, influenced by factors such as advancements in technology, increasing prevalence of gastrointestinal disorders, and a growing emphasis on minimally invasive surgical procedures among healthcare providers.

Customer preferences:
In Greece, there is a noticeable shift towards patient-centered care, with consumers increasingly prioritizing less invasive treatment options for gastrointestinal issues. This trend is fueled by a growing awareness of the benefits of minimally invasive procedures, which promise quicker recovery times and reduced hospital stays. Additionally, the aging population is driving demand for endoscopic devices, as older adults are more prone to gastrointestinal disorders. Cultural attitudes favoring holistic health approaches further encourage the adoption of advanced endoscopic technologies among healthcare providers.

Trends in the market:
In Greece, the Endoscopic Devices Market is experiencing a significant transition towards advanced minimally invasive technologies, driven by a shift in patient preferences for less invasive gastrointestinal treatments. This trend is supported by increased investment in innovative endoscopic solutions, which facilitate quicker recovery and shorter hospital stays. Moreover, the aging population intensifies the demand for these devices, as older adults commonly face gastrointestinal disorders. The emphasis on holistic health further propels healthcare providers to integrate cutting-edge endoscopic technologies, impacting industry stakeholders by creating opportunities for innovation and collaboration.

Local special circumstances:
In Greece, the Endoscopic Devices Market is shaped by a combination of geographical and cultural factors that influence healthcare delivery. The country's strong emphasis on traditional medicine and holistic approaches often leads to a cautious adoption of advanced technologies. However, the increasing prevalence of gastrointestinal disorders among the aging population drives demand for innovative endoscopic solutions. Additionally, Greece's regulatory environment encourages collaboration between public and private sectors, fostering investment in minimally invasive techniques and enhancing access to cutting-edge medical technologies.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Greece is significantly influenced by macroeconomic factors, including national economic stability, healthcare spending, and regulatory frameworks. The country’s economic recovery post-crisis has led to increased public and private investment in healthcare, driving demand for advanced medical technologies. Favorable fiscal policies that support innovation and research are further enhancing market growth. Additionally, the rising incidence of gastrointestinal disorders among an aging population necessitates the adoption of minimally invasive procedures. Global trends towards improved healthcare access and technological advancements also play a vital role in shaping the endoscopic devices landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)